4th Edelris Symposium on AS-MS in Drug Discovery
The 4th Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery will take place online on May 15-16, 2024 from 16:00 until 18:30 CET.
Over the years, AS-MS has become a mature screening technology for Hit-Identification, particularly for difficult-to-drug targets such as membrane proteins, transcription factors or RNAs. More broadly, technologies based on Mass detection readings have contributed to significantly broadening the field of possibilities in screening.
This year’s Symposium will cover different approaches taken by academic and industry groups in the areas of natural products, macrocycles and small synthetic molecules to drive innovative drug discovery.
Previous events
2023 Edition
The program focused on the techniques developed by pharma and CRO organizations to implement AS-MS in their drug discovery process. Automated Data Processing was discussed and the synergy with other HTS technologies, particularly DELT, was emphasized.
2022 Edition
The program covered several aspects of AS-MS, featuring recent technological developments and exciting results on hot targets using various chemical matters including ultra-large libraries of peptides.
2021 Edition
The 1st Edelris Symposium highlighted the use of Affinity Selection-Mass Spectrometry (AS-MS) techniques to explore broad chemical spaces – biased collections, natural products, and large libraries.